Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gamma delta T-cell therapy - Kiromic

Next Previous
Drug Profile

Gamma delta T-cell therapy - Kiromic

Alternative Names: Deltacel; Deltacel/KB-GDT; Gamma delta T-cell therapy - Kiromic Biopharma; KB-GDT-01; KB-GDT™

Latest Information Update: 03 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kiromic
  • Class Antineoplastics; CAR-T cell therapies; Immunotherapies; T lymphocyte cell therapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Non-small cell lung cancer

Most Recent Events

  • 18 Feb 2025 Updated efficacy data from a phase I trial in Non-small cell lung cancer released by Kiromic Biopharma
  • 22 Jan 2025 Updated efficacy data from a phase I trial in Non-small cell lung cancer released by Kiromic Biopharma
  • 12 Dec 2024 Updated efficacy data from the phase I Deltacel-01 trial in Non-small cell lung cancer released by Kiromic Biopharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top